Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants
Name | Tapentadol 150mg modified-release tablets |
BNF code | 0407020AGAAAEAE |
Virtual Therapeutic Moiety | Tapentadol |
Basis of preferred name | rINN - Recommended International Non-proprietary |
Prescribing status | Valid as a prescribable product |
Sugar free | ✗ |
Gluten free | ✗ |
Preservative free | ✗ |
CFC free | ✗ |
Dose form | Discrete |
Unit dose form size | 1.000 |
Unit dose form units | tablet |
Unit dose unit of measure | tablet |
Virtual Product Ingredient | |
---|---|
Ingredient | Tapentadol |
Basis of pharmaceutical strength | Based on Ingredient Substance |
Strength value numerator | 150.000 |
Strength value numerator unit | mg |
Ontology Drug Form & Route | |
Form & Route | tabletmodified-release.oral |
Dose Form | |
Formulation | Modified-release tablet |
Drug Route | |
Route | Oral |
Controlled Drug Prescribing Information | |
Controlled Drug category | Schedule 2 (CD) |
Actual Medicinal Products | |
Ationdo SR 150mg tablets (Grunenthal Ltd) | |
Lupaxis 150mg prolonged-release tablets (Dr Reddy's Laboratories (UK) Ltd) | |
Palexia SR 150mg tablets (Grunenthal Ltd) | |
Tadomon 150mg prolonged-release tablets (G.L. Pharma UK Ltd) | |
Tapentadol 150mg modified-release tablets (A A H Pharmaceuticals Ltd) | |
Tapentadol 150mg modified-release tablets (Alliance Healthcare (Distribution) Ltd) | |
Tapentadol 150mg modified-release tablets (Aspire Pharma Ltd) | |
Tapentadol 150mg modified-release tablets (Krka UK Ltd) | |
Tapentadol 150mg modified-release tablets (Medical Valley Invest AB) | |
Tapentadol 150mg modified-release tablets (Medihealth (Northern) Ltd) | |
Tapentadol 150mg modified-release tablets (Viatris UK Healthcare Ltd) | |
Vecicom 150mg prolonged-release tablets (Celix Pharma Ltd) | |
Virtual Medicinal Product Packs | |
Tapentadol 150mg modified-release tablets 56 tablet |
dm+d data retrieved from TRUD: release NHSBSA_2.2.0_20250217000001, imported on 18th February 2025 at 03:53:40.